Related references
Note: Only part of the references are listed.The Prodrug Platin-A: Simultaneous Release of Cisplatin and Aspirin
Rakesh K. Pathak et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Platinum(IV) Prodrugs with Haloacetato Ligands in the Axial Positions can Undergo Hydrolysis under Biologically Relevant Conditions
Ezequiel Wexselblatt et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Synthesis and Characterization of Pt(IV) Fluorescein Conjugates to Investigate Pt(IV) Intracellular Transformations
Ying Song et al.
BIOCONJUGATE CHEMISTRY (2013)
Facile Preparation of Mono-, Di- and Mixed-Carboxylato Platinum(IV) Complexes for Versatile Anticancer Prodrug Design
Jenny Z. Zhang et al.
CHEMISTRY-A EUROPEAN JOURNAL (2013)
The Effect of Ligand Lipophilicity on the Nanoparticle Encapsulation of Pt(IV) Prodrugs
Timothy C. Johnstone et al.
INORGANIC CHEMISTRY (2013)
Cyclodextrin Capped Gold Nanoparticles as a Delivery Vehicle for a Prodrug of Cisplatin
Yi Shi et al.
INORGANIC CHEMISTRY (2013)
Multifunctionalization of Polymers by Strain-Promoted Cycloadditions
Petr A. Ledin et al.
MACROMOLECULES (2013)
αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug
Nora Graf et al.
ACS NANO (2012)
Bioorthogonal Copper-Free Click Chemistry In Vivo for Tumor-Targeted Delivery of Nanoparticles
Heebeom Koo et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Nazila Kamaly et al.
CHEMICAL SOCIETY REVIEWS (2012)
What do we know about the reduction of Pt(IV) pro-drugs?
Ezequiel Wexselblatt et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Nanoparticles: the future for platinum drugs or a research red herring?
Nial J. Wheate
NANOMEDICINE (2012)
Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics
Sean Marrache et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Jeffrey Hrkach et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Bioconjugation with Strained Alkenes and Alkynes
Marjoke F. Debets et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
From Mechanism to Mouse: A Tale of Two Bioorthogonal Reactions
Ellen M. Sletten et al.
ACCOUNTS OF CHEMICAL RESEARCH (2011)
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Surface Functionalization Using Catalyst-Free Azide-Alkyne Cycloaddition
Alexander Kuzmin et al.
BIOCONJUGATE CHEMISTRY (2010)
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy
Nagesh Kolishetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Bioorthogonal Chemistry: Fishing for Selectivity in a Sea of Functionality
Ellen M. Sletten et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Inhibition of transcription by platinum antitumor compounds
Ryan C. Todd et al.
METALLOMICS (2009)
Nanotechnology for drug delivery: the perfect partnership
Omid C. Farokhzad
EXPERT OPINION ON DRUG DELIVERY (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles
Shanta Dhar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Nanoparticles in medicine: Therapeutic applications and developments
L. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Basis for design and development of Platinum(IV) anticancer complexes
Matthew D. Hall et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Cellular processing of platinum anticancer drugs
D Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Nanoparticle and targeted systems for cancer therapy
L Brannon-Peppas et al.
ADVANCED DRUG DELIVERY REVIEWS (2004)
Nanopartide-aptamer bioconjugates: A new approach for targeting prostate cancer cells
OC Farokhzad et al.
CANCER RESEARCH (2004)
Biodegradable polymeric nanoparticles as drug delivery devices
KS Soppimath et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Share Paper
